Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
NCT06775912
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
SLE
Systemic Sclerosis
IIM
NMOSD
MS
MG
ANCA Associated Vasculitis (AAV)
Interventions
DRUG:
RD06-05 CART Cell Injection
Sponsor
Nanjing Bioheng Biotech Co., Ltd.